Haemonetics (HAE) Proxy filing summary

Voting matters and shareholder proposals

• Election of eight director nominees to serve one-year terms expiring in 2027.

• Advisory vote to approve compensation of named executive officers.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending April 3, 2027.

• Approval of amendments and restatements to the 2019 Long-Term Incentive Compensation Plan and the 2007 Employee Stock Purchase Plan.

• Other business may be transacted as properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and FOR all proposals listed.

• Shareholders of record as of May 22, 2026, are eligible to attend and vote at the meeting.

Executive compensation and say-on-pay

• Advisory vote scheduled to approve compensation of named executive officers.

• Proposed amendment and restatement of the Long-Term Incentive Compensation Plan.